“…The IGHV transcriptome in CSF of MS patients did, however, to a larger extent reflect intrathecal synthesis of IgG, and was characterized by more pronounced affinity maturation and selective use of IGHV4 genes. It has previously been reported that IGHV transcripts recovered from CSF and CNS B cells of MS patients have undergone somatic hypermutation [16,22,23,[33][34][35], have biased IGHV gene usage [15,20], match CSF IgG [19,21], and communicate across the blood-brain barrier [20,21,23,35]. The sequencing depth achieved using Illumina technology, combined with mass-spectrometric verification, allowed us to extend these findings by showing that all examined MS patients, regardless of disease duration and therapy, had closely related IGH-VDJ transcripts on both sides of the blood-CSF barrier.…”